Almitas Capital »

Cortexyme shares owned by Almitas Capital

Quarter-by-quarter ownership of Cortexyme (QNCX) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Cortexyme

Tip: Access up to 7 years of quarterly data

All positions including Cortexyme held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cortexyme by Almitas Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $297k 383k 0.78

More positions owned by Almitas Capital

Fidelity Wise Origin Bitcoin Fund SHS (FBTC)
BlackRock Health Sciences Term Trust Com Shs (BMEZ)
Nuveen PA Investnt Quality Municipal (NQP)
Miller/Howard High Dividend Fund Com Shs Ben In (HIE)
BlackRock Municipal 2030 Target Term Trust Com Shs Ben In (BTT)
Tortoise Midstream Energy M (NTG)
Mainstay Definedterm Mn Opp (MMD)
Bny Mellon Mun Income (DMF)
Pgim Short Dur Hig Yld Opp F (SDHY)
Design Therapeutics (DSGN)
Eaton Vance New York Municipal Bond Fund (ENX)
Amylyx Pharmaceuticals (AMLX)
Western Asset Invest. Grade Defined Opp (IGI)
BlackRock ESG Capital Allocation Term Trust Shs Ben Int (ECAT)
Tortoise Pipeline & Energy F (TTP)

View all positions for Almitas Capital

Top funds holding Cortexyme

Vanguard Group
EPIQ Capital Group
Renaissance Technologies
Almitas Capital
BlackRock
BlackRock
HighTower Advisors
Geode Capital Management
Alphabet
Bank of America Corporation
Bridgeway Capital Management
Mariner Wealth Advisors
Citadel Advisors
Two Sigma Advisers
State Street Corporation

View all funds holding Cortexyme